Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure
Open accessThe DOI matches its Crossref record.
Abstract
: High lipoprotein(a) (Lp(a)) serum concentrations and the underlying apolipoprotein(a) (apo(a)) phenotypes are risk factors for cardiovascular disease in the general population as well as in patients with renal disease. Lp(a) concentrations are markedly elevated in patients with end-stage renal disease. However, nothing is known about the changes of Lp(a) depending on apo(a) size polymorphism in the earliest stages of renal impairment. In this study, GFR was measured by iohexol technique in 227 non-nephrotic patients with different degrees of renal impairment and was then correlated with Lp(a) serum concentrations stratified according to low (LMW) and high (HMW) molecular weight apo(a) phenotypes. Lp(a) increased significantly with decreasing GFR. Such an increase was dependent on apo(a) phenotype. Only renal patients with HMW apo(a) phenotypes expressed higher median Lp(a) concentrations, i.e., 6.2 mg/dl at GFR >90 ml/min per 1.73 m 2, 14.2 at GFR 45 to 90 ml/min per 1.73 m 2, and 18.0 mg/dl at GFR <45 ml/min per 1.73 m 2. These values were markedly different when compared with apo(a) phenotype-matched control subjects who had a median level of 4.4 mg/dl (ANOVA, linear relationship, P < 0.001). In contrast, no significant differences were observed at different stages of renal function in patients with LMW apo(a) phenotypes when compared with phenotype-matched control subjects. The elevation of Lp(a) was independent of the type of primary renal disease and was not related to the concentration of C-reactive protein. Multiple linear regression analysis found that the apo(a) phenotype and GFR were significantly associated with Lp(a) levels. Non-nephrotic-range proteinuria modified the association between GFR and Lp(a) levels. In summary, an increase of Lp(a) concentrations, compared with apo(a) phenotype-matched control subjects, is seen in non-nephrotic patients with primary renal disease even in the earliest stage when GFR is not yet subnormal. This change is found only in subjects with HMW apo(a) phenotypes, however.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Self-citationK/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Self-citationMatsushita, K., Mahmoodi, B. K., Woodward, M., Emberson, J. R., Jafar, T. H., Jee, S. H., Polkinghorne, K. R., Shankar, A., Smith, D. H., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.3954 · Cited by 988
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
Shlipak, M. G., Matsushita, K., Ärnlöv, J., Inker, L. A., Katz, R., Polkinghorne, K. R., Rothenbacher, D., Sarnak, M. J., Astor, B. C., Coresh, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214234 · Cited by 980
Structure, function, and genetics of lipoprotein (a)
Schmidt, K., Noureen, A., Kronenberg, F., & Utermann, G. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067314 · Cited by 638
Self-citationAge and Association of Kidney Measures With Mortality and End-stage Renal Disease
Hallan, S. I., Matsushita, K., Sang, Y., Mahmoodi, B. K., Black, C., Ishani, A., Kleefstra, N., Naimark, D., Roderick, P., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.16817 · Cited by 636
Lipoprotein(a): resurrected by genetics
Kronenberg, F., & Utermann, G. (2013) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02592.x · Cited by 521
Self-citationBiomarkers in chronic kidney disease: a review
Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449
Bostom, A. G., Kronenberg, F., & Ritz, E. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000022011.35035.f3 · Cited by 410
Self-citationKielstein, J. T., Bo[Combining Diaeresis]ger, R. H., Bode-Bo[Combining Diaeresis]ger, S. M., Fro[Combining Diaeresis]lich, J. D. C., Haller, H., Ritz, E., & Fliser, D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131170 · Cited by 369
Self-citationLipoprotein metabolism and lipid management in chronic kidney disease
Kwan, B. C. H., Kronenberg, F., Beddhu, S., & Cheung, A. K. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091006 · Cited by 354
Self-citationModerate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I
Garg, A. X., Clark, W. F., Haynes, R. B., & House, A. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00270.x · Cited by 314
Fliser, D., Kronenberg, F., Kielstein, J. T., Morath, C., Bode-Bo[Combining Diaeresis]ger, S. M., Haller, H., & Ritz, E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020179 · Cited by 312
Self-citationLipoprotein (a): impact by ethnicity and environmental and medical conditions
Enkhmaa, B., Anuurad, E., & Berglund, L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r051904 · Cited by 260
Roeseler, E., Julius, U., Heigl, F., Spitthoever, R., Heutling, D., Breitenberger, P., Leebmann, J., Lehmacher, W., Kamstrup, P. R., Nordestgaard, B. G., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307983 · Cited by 227
Self-citationYeang (2015) · doi:10.1097/mol.0000000000000171 · Cited by 152
Lipid and lipoprotein metabolism in chronic kidney disease.
Kaysen, G. A. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.10.011 · Cited by 102
Dyslipidemia and nephrotic syndrome: recent advances.
Kronenberg, F. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.10.003 · Cited by 85
Self-citation
Metadata
- Authors
- KRONENBERG, F., KUEN, E., RITZ, E., JUNKER, R., KO[Combining Diaeresis]NIG, P., KRAATZ, G. D., LHOTTA, K., MANN, J. F. E., MU[Combining Diaeresis]LLER, G. A., NEYER, U., RIEGEL, W., RIEGLER, P., SCHWENGER, V., & VON ECKARDSTEIN, A.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2000-01
- Volume
- 11
- Issue
- 1
- Pages
- 105-115
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2147696440
- Cited by
- 248
- References
- 0
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.